These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21295029)

  • 21. Design and synthesis of new antimalarial agents from 4-aminoquinoline.
    Solomon VR; Puri SK; Srivastava K; Katti SB
    Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron chelators ICL670 and 311 inhibit HIV-1 transcription.
    Debebe Z; Ammosova T; Jerebtsova M; Kurantsin-Mills J; Niu X; Charles S; Richardson DR; Ray PE; Gordeuk VR; Nekhai S
    Virology; 2007 Oct; 367(2):324-33. PubMed ID: 17631934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum.
    Goudeau C; Loyevsky M; Kassim OO; Gordeuk VR; Nick H
    Br J Haematol; 2001 Dec; 115(4):918-23. PubMed ID: 11843826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.
    Nsumiwa S; Kuter D; Wittlin S; Chibale K; Egan TJ
    Bioorg Med Chem; 2013 Jul; 21(13):3738-48. PubMed ID: 23669191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines.
    Vennerstrom JL; Ager AL; Dorn A; Andersen SL; Gerena L; Ridley RG; Milhous WK
    J Med Chem; 1998 Oct; 41(22):4360-4. PubMed ID: 9784111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
    Dehkordi LS; Liu ZD; Hider RC
    Eur J Med Chem; 2008 May; 43(5):1035-47. PubMed ID: 17869385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm.
    Nazik H; Penner JC; Ferreira JA; Haagensen JA; Cohen K; Spormann AM; Martinez M; Chen V; Hsu JL; Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6514-20. PubMed ID: 26239975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670]2 for rat, marmoset, rabbit, mouse, dog, and human.
    Weiss HM; Fresneau M; Camenisch GP; Kretz O; Gross G
    Drug Metab Dispos; 2006 Jun; 34(6):971-5. PubMed ID: 16531476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bis-alkylamine Indolo[3,2-b]quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activities.
    Paulo A; Figueiras M; Machado M; Charneira C; Lavrado J; Santos SA; Lopes D; Gut J; Rosenthal PJ; Nogueira F; Moreira R
    J Med Chem; 2014 Apr; 57(8):3295-313. PubMed ID: 24673163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth.
    Vippagunta SR; Dorn A; Matile H; Bhattacharjee AK; Karle JM; Ellis WY; Ridley RG; Vennerstrom JL
    J Med Chem; 1999 Nov; 42(22):4630-9. PubMed ID: 10579825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of a new oral iron chelator, ICL670, and its iron complex in plasma by high-performance liquid chromatography and ultraviolet detection.
    Rouan MC; Marfil F; Mangoni P; Séchaud R; Humbert H; Maurer G
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):203-13. PubMed ID: 11393706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
    Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
    Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antimalarial activity of sulfonamide chalcone derivatives.
    Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
    Farmaco; 2005 Apr; 60(4):307-11. PubMed ID: 15848205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial.
    Walter PB; Macklin EA; Porter J; Evans P; Kwiatkowski JL; Neufeld EJ; Coates T; Giardina PJ; Vichinsky E; Olivieri N; Alberti D; Holland J; Harmatz P;
    Haematologica; 2008 Jun; 93(6):817-25. PubMed ID: 18469351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
    Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
    J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients.
    Chan GC; Chan S; Ho PL; Ha SY
    Hemoglobin; 2009; 33(5):352-60. PubMed ID: 19814682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon isosteres of the 4-aminopyridine substructure of chloroquine: effects on pK(a), hematin binding, inhibition of hemozoin formation, and parasite growth.
    Cheruku SR; Maiti S; Dorn A; Scorneaux B; Bhattacharjee AK; Ellis WY; Vennerstrom JL
    J Med Chem; 2003 Jul; 46(14):3166-9. PubMed ID: 12825955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry.
    Fischer R; Piga A; Harmatz P; Nielsen P
    Ann N Y Acad Sci; 2005; 1054():350-7. PubMed ID: 16339683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.
    Prus E; Fibach E
    Acta Haematol; 2010; 123(1):14-20. PubMed ID: 19923794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.